Free Test Strips and Blood Glucose Control - Full Text View

Sponsored by:	University of Wisconsin, Madison
Information provided by:	University of Wisconsin, Madison
ClinicalTrials.gov Identifier:	NCT00205335

Purpose

This study is designed to determine if there is an impact on blood glucose control in patients who receive free test strips. Patients in the study have no insurance or insurance that does not cover the purchase of test strips. A comparison of weight, blood pressure, and Hemoglobin A1C from entry to the final visit will be used to compare patients' management of their diabetes. Recommended values for these parameters will be used as the standard for comparisons. The investigators anticipate that patients receiving free test strips will show an improvement in the listed parameters as well as in satisfaction with their care.

Condition	Intervention
Diabetes	Device: Ascencia Breeze Glucose meter Device: Breeze Glucose Monitor (Bayer)

MedlinePlus related topics: Diabetes

Drug Information available for: Dextrose

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Non-Randomized, Open Label, Uncontrolled, Single Group Assignment
Official Title:	The Impact of Increased Availability of Test Strips on Blood Glucose Control in Patients With Diabetes

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:

Weight [ Time Frame: one year ] [ Designated as safety issue: No ]
Blood pressure [ Time Frame: one year ] [ Designated as safety issue: No ]
Hemoglobin A1C [ Time Frame: one year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Satisfaction with care [ Time Frame: one year ] [ Designated as safety issue: No ]

Enrollment:	22
Study Start Date:	January 2004
Study Completion Date:	November 2007
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
glucose monitoring Each participant received a Bayer Breeze Monitor and glucose test strips for monitoring blood sugar.	Device: Ascencia Breeze Glucose meter All study participants received glucose meter and test strips. Device: Breeze Glucose Monitor (Bayer) Each participant received a Breeze monitor and glucose test strips.

Show Detailed Description

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients with a diagnosis of diabetes who have no health insurance or insurance that does not pay for purchase of blood test strips

Exclusion Criteria:

Patients with a diagnosis of diabetes who have health insurance that pays for purchase of blood test strips

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205335

Locations

United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

University of Wisconsin, Madison

Investigators

Principal Investigator:

Sherree Drezner, ACSW, LCSW

University of Wisconsin, Madison

More Information

Responsible Party:	University of Wisconsin Hospital and Clinics ( Eileen Dalebroux, RN, CDE )
Study ID Numbers:	2004-1069
Study First Received:	September 13, 2005
Last Updated:	November 21, 2008
ClinicalTrials.gov Identifier:	NCT00205335
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on January 16, 2009